Mark Erlander Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Erlander.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Erlander. Mark Erlander is Chief Executive Officer in Cardiff Oncology, Inc. ($XNOM.OB) and Chief Scientific Officer in Trovagene, Inc. ($XNOM.OB).
Latest Insider Trading Transactions of Mark Erlander
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | P | 10.34 | 965 | 9,980 | 14,481 | 13.5 K to 14.5 K (+7.14 %) |
| Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Option Exercise | M | 0.00 | 260 | 0 | 0 | |
| Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 113 | 0 | 13,516 | 13.6 K to 13.5 K (-0.83 %) |
| Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | M | 0.00 | 260 | 0 | 13,629 | 13.4 K to 13.6 K (+1.94 %) |
| May 18 2020 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | P | 1.43 | 6,993 | 10,000 | 13,369 | 6.4 K to 13.4 K (+109.68 %) |
| Oct 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 1,771 | |
| Oct 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 466 | 0 | 5,533 | 6 K to 5.5 K (-7.77 %) |
| Oct 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 1,250 | 0 | 5,999 | 4.7 K to 6 K (+26.32 %) |
| Jul 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,021 | |
| Jul 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 461 | 0 | 4,749 | 5.2 K to 4.7 K (-8.85 %) |
| Jul 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 1,250 | 0 | 5,210 | 4 K to 5.2 K (+31.57 %) |
| Jun 24 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 2.48 | 134,203 | 332,823 | 158,959 | |
| Apr 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 4,271 | |
| Apr 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 459 | 0 | 3,960 | 4.4 K to 4 K (-10.39 %) |
| Apr 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 1,250 | 0 | 4,419 | 3.2 K to 4.4 K (+39.44 %) |
| Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,563 | 0 | 33,125 | |
| Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 698 | 0 | 19,010 | 19.7 K to 19 K (-3.54 %) |
| Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 1,563 | 0 | 19,708 | 18.1 K to 19.7 K (+8.61 %) |
| Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 7,500 | 0 | 34,688 | |
| Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 3,035 | 0 | 18,145 | 21.2 K to 18.1 K (-14.33 %) |
| Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 7,500 | 0 | 21,180 | 13.7 K to 21.2 K (+54.82 %) |
| Oct 03 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 7,500 | 0 | 42,188 | |
| Oct 03 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 2,731 | 0 | 13,680 | 16.4 K to 13.7 K (-16.64 %) |
| Oct 03 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 7,500 | 0 | 16,411 | 8.9 K to 16.4 K (+84.17 %) |
| Jul 26 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 45,000 | 0 | 49,688 | |
| Feb 01 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 90,000 | 0 | 56,250 | |
| Feb 01 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 42,930 | 0 | 104,367 | 147.3 K to 104.4 K (-29.15 %) |
| Feb 01 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 90,000 | 0 | 147,297 | 57.3 K to 147.3 K (+157.08 %) |
| Jan 25 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.30 | 672,189 | 201,657 | 1,782,189 | |
| Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 18,750 | 0 | 146,250 | |
| Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 9,558 | 0 | 57,243 | 66.8 K to 57.2 K (-14.31 %) |
| Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 18,750 | 0 | 66,801 | 48.1 K to 66.8 K (+39.02 %) |
| Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 30,001 | 0 | 165,000 | |
| Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 12,928 | 0 | 48,051 | 61 K to 48.1 K (-21.20 %) |
| Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 30,001 | 0 | 61,033 | 31 K to 61 K (+96.68 %) |
| Aug 24 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.85 | 385,000 | 327,250 | 1,110,000 | |
| Apr 10 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 90,000 | 0 | 195,001 | |
| Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 75,000 | 0 | 105,001 | |
| Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 30,001 | 0 | 30,001 | |
| Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 50,000 | 0 | 0 | |
| Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 23,968 | 0 | 31,032 | 55 K to 31 K (-43.58 %) |
| Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 50,000 | 0 | 55,000 | 5 K to 55 K (+1,000.00 %) |
| Dec 15 2016 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | P | 2.08 | 5,000 | 10,375 | 5,000 | 0 to 5 K |
| May 04 2016 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 06 2016 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 5.18 | 150,000 | 777,000 | 725,000 |
Page: 1